AI Innovation Lab collaboration with InstaDeep

BioNTech and InstaDeep announced a multi-year collaboration to apply artificial intelligence and machine learning to novel immunotherapies for cancers and infectious diseases. They said they will form a joint AI Innovation Lab in London and Mainz covering drug discovery and design, protein engineering, manufacturing and supply-chain optimization. The release also says BioNTech plans to use AI and machine-learning applications to optimize manufacturing and supply-chain processes.